MALVERN, Pa., Oct. 02, 2017 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology, has been named one of the Best Places to Work in PA for 2017. The awards program, created in 2000, is one of the first statewide programs of its kind in the country. The program is a public/private partnership between Team Pennsylvania Foundation, the Pennsylvania Department of Community and Economic Development, the Pennsylvania State Council of the Society for Human Resource Management, and the Central Penn Business Journal.
“It is a great honor to be named one of the Best Places to Work in Pennsylvania, and I’m pleased to share this award with all of my colleagues who help make Aclaris an exceptional company,” said Dr. Neal Walker, President and Chief Executive Officer of Aclaris. “We have built an extraordinary team of people who are committed to developing and commercializing new medical and aesthetic dermatology treatment options for patients with visible skin and hair conditions.”
This survey and awards program was designed to identify, recognize and honor the best places of employment in Pennsylvania, who are benefiting the state's economy and its workforce. Employers are categorized based upon the total number of employees they have in the United States, 15 to 99 employees, 100 to 250 employees, or more than 250 employees.
To be considered for participation, companies had to fulfill the following eligibility requirements:
- Be a for-profit or not-for-profit business
- Be a publicly or privately held business
- Have a facility in Pennsylvania
- Have at least 15 employees working in Pennsylvania
- Be in business a minimum of one year
Companies from across the state entered the two-part process to determine the 100 Best Places to Work in PA. The first part of this process was evaluating each nominated company's workplace policies, practices, philosophies, systems and demographics. This part of the process was worth approximately 25% of the total evaluation. The second part consisted of an employee survey to measure the employee experience. This part of the process was worth approximately 75% of the total evaluation. The combined scores determined the top companies and the final ranking. Best Companies Group managed the overall registration and survey process.
Aclaris will be recognized at the Best Places to Work in PA awards banquet on Thursday, November 30, 2017, at the Lancaster County Convention Center in Lancaster, PA. Rankings will be revealed at the ceremony. Tickets may be purchased online at www.CPBJ.com/events.
In addition to the public/private partnership, the program is supported by the following organizations: Lead Sponsor—Team Pennsylvania Foundation; Major Sponsor—Saul Ewing Arnstein & Lehr; Founding Partners—Team Pennsylvania Foundation, the Pennsylvania State Council of the Society for Human Resource Management, and the Central Penn Business Journal; Program Partners—The Department of Community and Economic Development and PA SHRM.
For more information on the Best Places to Work in PA, visit www.bestplacestoworkinpa.com or contact Olivia Berrigan, event coordinator at the Central Penn Business Journal at 717-323-5250 or [email protected].
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris is based in Malvern, Pennsylvania and more information can be found by visiting Aclaris’ website at www.aclaristx.com.
Contact:
Aclaris Contact
Michael Tung, M.D.
Vice President / Investor Relations
484-329-2140
[email protected]
Media Contact
Mariann Caprino
TogoRun
917-242-1087
[email protected]


Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



